ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
基本信息
- 批准号:7739032
- 负责人:
- 金额:$ 16.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-Protein PrecursorBrainCellsCholesterolCholesterol HomeostasisCrossbreedingEnzymesEtiologyGenerationsGenesGoalsHomeostasisHumanIn VitroInvestigationKnock-outKnockout MiceKnowledgeLinkLysosomesMediatingMembraneMembrane MicrodomainsMetabolismMicroarray AnalysisMusMutationNeurogliaNeuronsPathway interactionsPeptidesPreventionProcessProductionProtein DynamicsProteinsProteolytic ProcessingRegulationRoleTg2576Transgenic MiceTransgenic OrganismsUrsidae Familyamyloid precursor protein processingbasecholesterol traffickingclinically relevanthuman TAP2 proteinin vivolate endosomemind controlmouse modelmutantnovelpromoterpublic health relevancesecretasetherapeutic development
项目摘要
DESCRIPTION (provided by applicant): Project Summary: The long-term goals of this project focus on establishing the ATP-binding cassette transporter-2 (ABCA2) as a novel regulator of proteolytic processing of the amyloid precursor protein (APR). Amyloidogenic processing of APP results in the generation of A-beta peptide cleavage products that are implicated in the etiology of Alzheimer's disease (AD). The complete elucidation of the mechanisms that regulate APP processing and Ap production has not been realized. One mechanism that regulates APP processing is the cholesterol trafficking-dependent localization of APP and key enzymes that mediate its proteolytic cleavage in membrane compartments. ABCA2 may function to modulate intracellular cholesterol trafficking of exogenous llpoprotein-derived cholesterol from late-endosomes/lysosomes to membrane compartments. We identified ABCA2 as a regulator of APP processing and A-beta production in vitro. We determined that cellular APP holoprotein levels and A-beta secretion were increased in non-neuronal HEK293 cells that stably co-expressed ABCA2 and APP bearing the APP "Swedish" mutation. We also detected increased expression of a number of genes associated with AD using microarray analysis in HEK293 cells that stably expressed ABCA2. Although evidence suggests that ABCA2 may be a key regulator of APP metabolism, perhaps by regulation of intracellular cholesterol trafficking and distribution, we have not examined the effects of ABCA2 function in either neuronal cells or in the brains of transgenic mice expressing mutant forms of APP. Our recent production of ABCA2 knockout mice and ABCA2 transgenic mice under the control of the brain-specific Thy-1 promoter will permit the investigation of this novel function of the ABCA2 transporter in regulating APP processing and A-beta production in vivo in transgenic mouse models of AD. Our preliminary results have led us to the novel hypothesis that ABCA2 acts to regulate APP processing and A-beta production through modulation of intracellular cholesterol trafficking-dependent localization of APP and key processing enzymes in membrane compartments.
Public Health Relevance: These studies may provide novel and mechanistic links between cholesterol metabolism and APP processing that could be of direct clinical relevance. In depth knowledge of the mechanisms of action of the ABCA2 transporter on regulation of APP processing may provide a basis for the development of therapeutic strategies in prevention and treatment of AD.
描述(由申请人提供): 项目摘要:该项目的长期目标侧重于建立 ATP 结合盒转运蛋白 2 (ABCA2) 作为淀粉样前体蛋白 (APR) 蛋白水解过程的新型调节剂。 APP 的淀粉样蛋白形成过程会导致 A-β 肽裂解产物的产生,这些产物与阿尔茨海默病 (AD) 的病因学有关。尚未完全阐明调节 APP 加工和 Ap 生产的机制。调节 APP 加工的一种机制是 APP 的胆固醇运输依赖性定位以及介导其在膜区室中蛋白水解裂解的关键酶。 ABCA2 可能起到调节外源脂蛋白衍生胆固醇从晚期内体/溶酶体到膜区室的细胞内胆固醇运输的作用。我们确定 ABCA2 是体外 APP 加工和 A-β 产生的调节剂。我们确定,在稳定共表达 ABCA2 和带有 APP“Swedish”突变的 APP 的非神经元 HEK293 细胞中,细胞 APP 全蛋白水平和 A-β 分泌增加。我们还在稳定表达 ABCA2 的 HEK293 细胞中使用微阵列分析检测到许多与 AD 相关的基因表达增加。尽管有证据表明 ABCA2 可能是 APP 代谢的关键调节因子,可能是通过调节细胞内胆固醇运输和分布来实现的,但我们尚未研究 ABCA2 功能对神经元细胞或表达突变形式 APP 的转基因小鼠大脑的影响。我们最近在大脑特异性 Thy-1 启动子控制下生产了 ABCA2 敲除小鼠和 ABCA2 转基因小鼠,这将允许在 AD 转基因小鼠模型中研究 ABCA2 转运蛋白在体内调节 APP 加工和 A-β 产生的新功能。我们的初步结果使我们得出了一个新的假设,即 ABCA2 通过调节细胞内胆固醇运输依赖性 APP 和膜区室中关键加工酶的定位来调节 APP 加工和 A-β 产生。
公共卫生相关性:这些研究可能提供胆固醇代谢和 APP 处理之间新颖的机制联系,可能具有直接的临床相关性。深入了解 ABCA2 转运蛋白对 APP 加工调节的作用机制可能为制定预防和治疗 AD 的治疗策略提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WARREN DAVIS其他文献
WARREN DAVIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WARREN DAVIS', 18)}}的其他基金
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
8139674 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
8533026 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
8316298 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7959965 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
7934484 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7720846 - 财政年份:2008
- 资助金额:
$ 16.57万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7610450 - 财政年份:2007
- 资助金额:
$ 16.57万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7381855 - 财政年份:2006
- 资助金额:
$ 16.57万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 16.57万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 16.57万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 16.57万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 16.57万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 16.57万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 16.57万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 16.57万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 16.57万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 16.57万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 16.57万 - 项目类别:














{{item.name}}会员




